-
Give before midnight TONIGHT to double your impact in developing PPMD’s DCRN
Happy New Year’s Eve! We’re almost there. At midnight we will ring in a new […]
-
Double your impact in advancing the research evolution by the end of 2024
As the clock winds down on 2024 and we prepare to ring in the new […]
-
How my sons’ DMD progression has changed my outlook
In the past 12 months, our oldest daughter got married, our oldest son moved across […]
-
Together, let’s advance the research evolution
For my fellow adults living with Duchenne and Becker, today’s reality is vastly different from […]
-
Even with hearing aids, I still have difficulty in group settings
Facioscapulohumeral muscular dystrophy (FSHD) primarily affects muscles in the face, scapular region, and upper arms, […]
-
Life is about time and timing when living with Duchenne
As a family living with Duchenne, time is everything to us. Decades of trials and […]
-
How I measure my quality of life as someone with LGMD
Since I began writing for Bionews, the parent company of Muscular Dystrophy News Today, I’ve […]
-
How I’ve learned to embrace the highs and lows of caregiving
In the past few weeks, as I’ve sat down at my laptop to write my […]
-
Percheron Therapeutics ends clinical trial in Australia and Europe after data indicates no benefits after 6 months of treatment with avicursen (ATL1102)
Australian company Percheron Therapeutics released topline 6-month data from its Phase 2 study of avicursen […]
-
Over 20 new MDA grants will fund research into muscle diseases
The Muscular Dystrophy Association (MDA) has awarded nearly two dozen new grants to fund research […]
